A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101

NCT04655911 · clinicaltrials.gov ↗
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Abeona has decided to discontinue development activities for Product AB0-101 due to a lack of drug supply and for business reasons unrelated to the product safety profile and/or signs of efficacy

Conditions

Interventions

Sponsor

Abeona Therapeutics, Inc